# OnCo record treadwell-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/treadwell-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "treadwell-therapeutics" ;
  schema:name "Treadwell Therapeutics"@en ;
  schema:alternateName "Treadwell Therapeutics, Inc"@en ;
  schema:description "Treadwell Therapeutics is a Hong Kong-based biotechnology company running 3 late-stage cancer trials of CFI-402411, CFI-400945 and CFI-402257 in acute myeloid leukaemia, myelodysplastic syndromes / neoplasms and HR-positive / HER2-negative breast cancer."@en ;
  schema:url <https://onco.cc/companies/treadwell-therapeutics/>, <https://treadwelltx.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://treadwelltx.com>, <https://clinicaltrials.gov/search?lead=Treadwell%20Therapeutics%2C%20Inc>, <https://treadwelltx.com/pipeline/> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "HK" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:trials <https://onco.cc/trials/nct04730258/>, <https://onco.cc/trials/nct04521413/>, <https://onco.cc/trials/nct05251714/> .